ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer

Itsuto Hamano; Shingo Hatakeyama; Tomoko Hamaya; Kyo Togashi; Teppei Okamoto; Hayato Yamamoto; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
IJU Case Reports2020DOI: 10.1002/iju5.12172
6阅读
引用收藏
分享

摘要

IntroductionCell‐free DNA is suggested as a prognostic biomarker in metastatic castration‐resistant prostate cancer. However, it remains unknown which parameter of cell‐free DNA is correlated with the progression and prognosis of metastatic castration‐resistant prostate cancer.Case presentationA 75‐year‐old man with newly diagnosed prostate cancer (serum prostate‐specific antigen 4891 ng/mL, Gleason score 4 + 5 = 9, cT3bN1M1) was referred to our department. He first received sequential hormonal therapies and was consequently diagnosed metastatic castration‐resistant prostate cancer 64 months after initial treatment. He underwent serial examinations of plasma cell‐free DNA, including concentration, androgen receptor amplification, TP53 point mutation, and PTEN loss. Only the cell‐free DNA concentration increased along with disease progression and declined after the administration of abiraterone and enzalutamide.ConclusionThis case presented that cell‐free DNA concentration was possibly correlated with response to castration‐resistant prostate cancer treatment and disease progression. Cell‐free DNA concentration was proposed as a potential prognostic biomarker of metastatic castration‐resistant prostate cancer.

学科与关键词

关键词
Androgen receptorBiomarkerCastration‐resistant prostate cancerCell‐free DNAConcentration
相关
加载中…
  • Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer
    Meijun, Du; Yijun, Tian; Winston, Tan; Liewei, Wang; Liguo, Wang; Deepak, Kilari; Chiang-Ching, Huang; Liang, Wang; Manish, KohliPROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23(4): 705-713.被引 2
  • Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer
    Manish Kohli; Winston Tan; Tiantian Zheng; Amy Wang; Carlos Montesinos; Calven Wong; Pan Du; Shidong Jia; Siddhartha Yadav; Lisa G. Horvath; Kate L. Mahon; Edmond M. Kwan; Heidi Fettke; Jianjun Yu; Arun A. AzadEBioMedicine, 2020, 54: 102728.
  • Circulating tumor DNA in patients with metastatic prostate cancer treated with abiraterone acetate
    Loriot, Y.*; Fizazi, K.Annals of Oncology, 2021, 32(6): 694-695.
查看全部 →

发表信息

论文状态
公开发表
期刊
IJU Case Reports
发表日期
2020
卷期
第 3 卷, 第 4 期
页码
141-144
DOI
10.1002/iju5.12172
成果收录
CHINAJOURNAL

作者

  • I

    Itsuto Hamano (第一作者)

  • S

    Shingo Hatakeyama

查看全部 10 位作者收起作者
  • T

    Tomoko Hamaya

  • K

    Kyo Togashi

  • T

    Teppei Okamoto

  • H

    Hayato Yamamoto

  • T

    Tohru Yoneyama

  • T

    Takahiro Yoneyama

  • Y

    Yasuhiro Hashimoto

  • C

    Chikara Ohyama

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417